ElectroCore Brings Next-Gen Vagus Nerve Stimulator To US With Innovative Sales Channel

US FDA cleared the gammaCore Sapphire non-invasive vagus nerve stimulator for the acute treatment of pain associated with migraine and episodic cluster headache. Electrocore also recently signed a deal with UpScript to provide a direct-to-patient sales channel for gammaCore.

MT1612_electroCore gammaCore_1200x675
electroCore's gammaCore non-invasive vagus nerve stimulator • Source: gammaCore LLC

More from Approvals

More from Policy & Regulation